Key figure year 2021

International committee of experts led by Professor Arndt Vogel updates ESMO treatment guidelines for biliary carcinoma

We provide information on current developments in liver cell cancer and Li-Fraumeni syndrome, a rare genetic disease, as well as a biomarker that could spare women with breast cancer chemotherapy. We will also introduce you to the Gesi-BK study, which is currently looking for relatives of people with advanced breast cancer in order to identify support needs for a care package.

Experts on the topic: MHH oncologist PD. Dr. Philipp Ivanyi and Professor Dr. Tanja Zimmermann, psycho-oncologist at the MHH.

Patient event of the MHH Cancer Center for patients, relatives and interested parties / Wednesday, November 9, 2022, from 5 to 6 p.m.

Topics include the new aftercare pass for cancer patients in Lower Saxony and the results of the Innovation Fund project "Effectiveness of care in oncology centers (WiZen)". In addition, two of our network partners will be presenting themselves again. We also provide information on upcoming events at the CCC-N.

Broadcast: Hallo Niedersachsen | 19.10.2022 | 19:30 h 3 min | Available until 19.10.2024

MHH research team has published a current overview of hepatocellular carcinoma (HCC) in The Lancet

The Digital Oncology Conference will also take place at the exhibition grounds as part of digitalhealth.PRO. The conference combines the Departments of Digitalization and Oncology and is an initiative of the Comprehensive Cancer Center Niedersachsen (CCC-N)

Dr. Marlene Röttger, assistant physician at the Clinical Department of Gynecology and Obstetrics at the MHH, explains what to look out for.

Expert lectures in cooperation with the CCC Hannover and the Clinical Department of Cardiology and Angiology of the MHH will start on October 4, 2022 in presence, Live via YouTube & Online

Whole-body MRI for the screening of Li-Fraumeni syndrome is covered by statutory health insurance.

National Cancer Prevention Week: The CCC Hannover takes part in the campaign week

With Jacqueline Ewest from the MHH Social Services.

Online event of the MHH Cancer Center for patients, relatives and interested parties on September 7, starting at 5 pm.

Genetic testing of healthy children is not recommended.

Patient University in cooperation with the in cooperation with the Comprehensive Cancer Center (CCC). Further information in the flyer.

The flyer gives you an overview of consultation hours and consultations, applications as well as courses and group programs at the center.

Study from the German Cancer Predisposition Register: the type of TP53 variant is decisive

Topics include the certification of our sarcoma center for bone and soft tissue tumors, the Johann-Georg-Zimmermann Research Prize awards and the visit of a delegation from the Indonesian Ministry of Health to strengthen cooperation in cancer medicine.

Passport and schemes can now be ordered online by Clinical Departments and practices / A project of the CCC-N, the LVG & AFS and the Lower Saxony Cancer Society

Treatment of rare tumors: In addition to soft tissue tumors, we are the only center in Lower Saxony to be recognized for bone sarcomas to date

Online information event of the MHH Cancer Center for patients, relatives and interested parties on Wednesday, June 29, 5 to 6 p.m.

Memorandum of Understanding signed to improve the quality of healthcare and research in oncology

Active participation in the treatment process for cancer patients.

The MHH plus Foundation honors Prof. Dr. Christoph Huber and PD Dr. Anna Saborowski / Award ceremony by Science Minister Björn Thümler and MHH President Prof. Michael Manns

Interview with Dr. Esmailzadeh, Coordinator of the Neuroncology Center and Senior Physician in the Clinical Department of Neurosurgery.

MHH involved in international study on acute myeloid leukemia (AML)

Kai-Christian Klespe, senior physician at the MHH Skin Tumor Center, explains in an interview how malignant changes in the skin can be detected and how malignant skin cancer can be treated.

Study center of the Clinical Department of Haematology, Haemostaseology, Oncology and Stem Cell Transplantation of the Hannover Medical School, investigator PD Dr. med. Philipp Ivanyi.

Online event of the MHH Cancer Center for patients, relatives and interested parties on May 4, 2022.

Joint press release of the AOK-Bundesverband, the Arbeitsgemeinschaft Deutscher Tumorzentren e. V. and the Center for Evidence-based Healthcare of the University Hospital Carl Gustav Carus Dresden and the Medical Faculty of the TU Dresden-

Online event series for patients, relatives and interested parties. Click here for the flyer.

Topics include the founding of the Klaus Bahlsen Center for Integrative Oncology, our new contacts in patient representation and the connection of the MHH to the communication platform of the German Consortium for Translational Cancer Research (DKTK).

The aim of the alliance is for patient involvement in cancer research to become a new standard in Germany in the long term. Together with the University Cancer Center Göttingen (G-CCC), we as CCC Lower Saxony are one of over 60 institutions that have joined the alliance. Further information and supporters can be found here.

Press release Association for Children with Cancer Hannover e.V.

Our focus topic: "One year of the Oncology Center of Excellence". In this interview, Prof. Volker Ellenrieder and Prof. Peter Hillemanns talk about the past and upcoming tasks as well as the regular change of spokespersons. We also asked the various departments what the award as a Center of Excellence means to them.

Colorectal Cancer Month was proclaimed by the Felix Burda Foundation, the LebensBlicke Foundation and the Netzwerk gegen Darmkrebs e.V. to raise awareness of colorectal cancer prevention. The CCC Hannover (Claudia von Schilling Center) is taking part in the month of action and providing information on the subject of bowel cancer (prevention).

Support our petition as part of RARE Disease Day 2022 - the International Day of Rare Diseases - for better funding of the Centres for Rare Diseases ZSE.

Excellent quality of care for increased risk of breast and/or ovarian cancer

Joint study by MHH and HZI: Vaccine proves safe and effective in liver fibrosis and liver cancer

NDR Visite: Broadcast from 15.02.2022, 20:15 with the participation of Prof. Diana Steinmann, Clinical Department of Radiotherapy and Special Oncology, Head of the Klaus Bahlsen Center for Integrative Oncology. Insights into the group program "Strengthen your self-healing powers" of the MHH (from minute 4:15).

This year, we are drawing attention to support services for cancer patients. To this end, some MHH employees have come together for a photo campaign. Click here for the photo gallery and the video library, where the departments report on their services.

A report on the free examination for early lung cancer detection in the Hanse Study mobile truck and the patient Gerhard Lunow, who was diagnosed with lung cancer in time and is now considered medically cured.

The association "Selbsthilfenetzwerk Kopf-Hals-M.U.N.D.-Krebs e.V." invites you to a Zoom information meeting on 26.01.2022 from 18.00 hrs.

Rut and Klaus Bahlsen Foundation supports the establishment with two million euros

Topics include the award of a young colleague from the Max Eder Young Investigator Program of the German Cancer Aid, the MHH membership in the European reference network GENTURIS and the first success story of the HANSE lung check study at the MHH.

Dr. Thomas Wirth, Senior Physician at the Clinical Department of Gastroenterology, Hepatology and Endocrinology at the MHH.